Xometry (NASDAQ:XMTR) Price Target Raised to $110.00

Posted by Geri Gentry on Aug 8th, 2026

Xometry (NASDAQ:XMTR – Free Report) had its target price hoisted by Cantor Fitzgerald from $85.00 to $110.00 in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The firm currently has an overweight rating on the stock.

XMTR has been the subject of several other research reports. Wedbush started coverage on shares of Xometry in a report on Thursday, July 16th. They set an “outperform” rating and a $126.00 price objective for the company. Citizens Jmp upped their price objective on shares of Xometry from $75.00 to $100.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. Citigroup increased their target price on shares of Xometry from $98.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday. Royal Bank Of Canada increased their target price on Xometry from $55.00 to $85.00 and gave the company a “sector perform” rating in a research report on Friday, May 8th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Xometry in a report on Friday, May 29th. Six research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $101.88.

Read Our Latest Research Report on XMTR

Xometry Trading Up 6.9%

Xometry stock opened at $93.14 on Wednesday. Xometry has a 12 month low of $35.86 and a 12 month high of $106.08. The company has a current ratio of 3.21, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The business’s fifty day simple moving average is $90.54 and its two-hundred day simple moving average is $68.38. The company has a market capitalization of $4.83 billion, a price-to-earnings ratio of -155.23 and a beta of 1.29.

Xometry (NASDAQ:XMTR – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.01. Xometry had a negative net margin of 3.82% and a negative return on equity of 2.88%. The company had revenue of $229.28 million during the quarter, compared to analyst estimates of $215.22 million. During the same period in the previous year, the business earned $0.09 EPS. The firm’s revenue for the quarter was up 41.1% on a year-over-year basis. As a group, equities analysts predict that Xometry will post -0.13 earnings per share for the current fiscal year.

Insider Transactions at Xometry

In other Xometry news, CFO James Miln sold 1,500 shares of the firm’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $87.92, for a total value of $131,880.00. Following the completion of the transaction, the chief financial officer owned 177,631 shares of the company’s stock, valued at approximately $15,617,317.52. This trade represents a 0.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Subir Dutt sold 1,073 shares of the business’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $93.39, for a total transaction of $100,207.47. Following the sale, the insider directly owned 93,716 shares in the company, valued at $8,752,137.24. This trade represents a 1.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 81,996 shares of company stock worth $7,256,220. 9.10% of the stock is currently owned by corporate insiders.

Institutional Trading of Xometry

Several large investors have recently added to or reduced their stakes in XMTR. Royal Bank of Canada grew its stake in shares of Xometry by 5.0% during the 1st quarter. Royal Bank of Canada now owns 60,669 shares of the company’s stock worth $1,511,000 after purchasing an additional 2,899 shares during the period. AQR Capital Management LLC purchased a new position in shares of Xometry in the 1st quarter valued at about $692,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Xometry by 7.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,054 shares of the company’s stock valued at $649,000 after purchasing an additional 1,877 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Xometry by 26.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 452,682 shares of the company’s stock worth $11,281,000 after purchasing an additional 95,154 shares during the period. Finally, Invesco Ltd. boosted its position in Xometry by 476.1% during the second quarter. Invesco Ltd. now owns 238,390 shares of the company’s stock worth $8,055,000 after purchasing an additional 197,013 shares in the last quarter. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Xometry Company Profile

(Get Free Report)

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.